Table of Contents
<< Previous Issue | May 2019 (Vol: 2019, Issue: 5) | Next Issue >> |
- Section: Licensing
-
Genentech and Parvus Therapeutics Collaborate on Autoimmune Diseases
-
Lilly Adds Centrexion’s Non-Opioid Pain Therapy to Pipeline
- Section: Mergers & Acquisitions
-
Lundbeck Rebuilds Neurology Pipeline with Abide Acquisition
-
Pfizer Acquires Rare Disease Specialist Therachon
-
Takeda’s Deleveraging Begins with Ethicon and Novartis Deals
-
Boston Scientific Acquires Spinal Device Company Vertiflex
-
Merck Bets on HIF-2α Inhibitors with Peloton Purchase
- Section: Research & Development
-
Gilead Forms Kidney Disease Pact with Goldfinch Bio
-
Vertex Joins Protein Degradation Space with Kymera Therapeutics Collaboration